Humacyte, Inc. (HUMA)
0.5856
+0.01
(+1.83%)
USD |
NASDAQ |
Sep 18, 16:00
0.5845
0.00 (0.00%)
After-Hours: 20:00
Humacyte Total Return Level : 0.5856 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 0.5856 |
| September 17, 2026 | 0.5751 |
| September 16, 2026 | 0.57 |
| September 15, 2026 | 0.5516 |
| September 14, 2026 | 0.561 |
| September 11, 2026 | 0.5676 |
| September 10, 2026 | 0.5671 |
| September 09, 2026 | 0.579 |
| September 08, 2026 | 0.5949 |
| September 04, 2026 | 0.6049 |
| September 03, 2026 | 0.596 |
| September 02, 2026 | 0.5966 |
| September 01, 2026 | 0.5704 |
| August 31, 2026 | 0.6014 |
| August 28, 2026 | 0.6501 |
| August 27, 2026 | 0.6927 |
| August 26, 2026 | 0.6816 |
| August 25, 2026 | 0.7012 |
| August 24, 2026 | 0.6622 |
| August 21, 2026 | 0.6422 |
| August 20, 2026 | 0.6814 |
| August 19, 2026 | 0.7349 |
| August 18, 2026 | 0.5817 |
| August 17, 2026 | 0.5606 |
| August 14, 2026 | 0.6048 |
| Date | Value |
|---|---|
| August 13, 2026 | 0.55 |
| August 12, 2026 | 0.665 |
| August 11, 2026 | 0.71 |
| August 10, 2026 | 0.7445 |
| August 07, 2026 | 0.7182 |
| August 06, 2026 | 0.7096 |
| August 05, 2026 | 0.7288 |
| August 04, 2026 | 0.7122 |
| August 03, 2026 | 0.6893 |
| July 31, 2026 | 0.6534 |
| July 30, 2026 | 0.6716 |
| July 29, 2026 | 0.6246 |
| July 28, 2026 | 0.6307 |
| July 27, 2026 | 0.6741 |
| July 24, 2026 | 0.6248 |
| July 23, 2026 | 0.6386 |
| July 22, 2026 | 0.6446 |
| July 21, 2026 | 0.6708 |
| July 20, 2026 | 0.6562 |
| July 17, 2026 | 0.6647 |
| July 16, 2026 | 0.6596 |
| July 15, 2026 | 0.6816 |
| July 14, 2026 | 0.7072 |
| July 13, 2026 | 0.6912 |
| July 10, 2026 | 0.6937 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Amgen, Inc. | 577.48 |
| Altimmune, Inc. | 12.61 |
| Protalix Biotherapeutics, Inc. | 2.69 |
| Taysha Gene Therapies, Inc. | 5.02 |
| Agenus, Inc. | 7.85 |